Co-Diagnostics, Inc. Common Stock (CODX) — Capital Reinvestment Ratio
Latest as of September 2022:
0.21x
Co-Diagnostics, Inc. Common Stock (CODX) has a Capital Reinvestment Ratio of 0.21x as of September 2022, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($230.05K). See CODX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.21x
Capex / Operating Cash Flow
Operating Cash Flow
$1.12 Million
USD
Capital Expenditures
$230.05K
USD
Data as of
Sep 2022
Most recent filing
Co-Diagnostics, Inc. Common Stock Capital Reinvestment Ratio (2020–2022)
This chart tracks Co-Diagnostics, Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Co-Diagnostics, Inc. Common Stock (2020–2022)
Year-by-year Capital Reinvestment Ratio for Co-Diagnostics, Inc. Common Stock from 2020 to 2022. For live market cap and broader valuation context, see CODX company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.22x | $6.57 Million | $1.43 Million | ▲ +1233.6% |
| 2021 | 0.02x | $41.08 Million | $669.46K | ▼ -40.7% |
| 2020 | 0.03x | $28.17 Million | $774.40K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow